These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34888241)
41. Novel Askaner G; Lei U; Bertelsen B; Venzo A; Wadt K Case Rep Genet; 2019; 2019():9650184. PubMed ID: 31485359 [TBL] [Abstract][Full Text] [Related]
42. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas. Menyhárt O; Győrffy B Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698 [TBL] [Abstract][Full Text] [Related]
43. Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies. Obrecht D; Mynarek M; Hagel C; Kwiecien R; Spohn M; Bockmayr M; Bison B; Pfister SM; Jones DTW; Sturm D; von Deimling A; Sahm F; von Hoff K; Juhnke BO; Benesch M; Gerber NU; Friedrich C; von Bueren AO; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Schüller U; Rutkowski S J Neurooncol; 2022 Mar; 157(1):37-48. PubMed ID: 35190934 [TBL] [Abstract][Full Text] [Related]
44. Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. Hinkes BG; von Hoff K; Deinlein F; Warmuth-Metz M; Soerensen N; Timmermann B; Mittler U; Urban C; Bode U; Pietsch T; Schlegel PG; Kortmann RD; Kuehl J; Rutkowski S J Neurooncol; 2007 Jan; 81(2):217-23. PubMed ID: 16941074 [TBL] [Abstract][Full Text] [Related]
45. Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker. Korshunov A; Okonechnikov K; Sahm F; Ryzhova M; Stichel D; Schrimpf D; Ghasemi DR; Pajtler KW; Antonelli M; Donofrio V; Mastronuzzi A; Rossi S; Camassei FD; Buccoliero AM; Haberler C; Slavc I; Dahiya S; Casalini B; Sievers P; Meyer J; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A Acta Neuropathol; 2020 Mar; 139(3):583-596. PubMed ID: 31781912 [TBL] [Abstract][Full Text] [Related]
46. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006 [TBL] [Abstract][Full Text] [Related]
47. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011 [TBL] [Abstract][Full Text] [Related]
48. Gorlin-like phenotype in a patient with a PTCH2 variant of uncertain significance. Casano K; Meddaugh H; Zambrano RM; Marble M; Torres JI; Lacassie Y Eur J Med Genet; 2020 Apr; 63(4):103842. PubMed ID: 31945512 [TBL] [Abstract][Full Text] [Related]
49. Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice. Svärd J; Rozell B; Toftgård R; Teglund S Mol Carcinog; 2009 May; 48(5):408-19. PubMed ID: 18781608 [TBL] [Abstract][Full Text] [Related]
50. Gorlin syndrome (nevoid basal cell carcinoma syndrome): update and literature review. Fujii K; Miyashita T Pediatr Int; 2014 Oct; 56(5):667-74. PubMed ID: 25131638 [TBL] [Abstract][Full Text] [Related]
51. Retrospective family study of childhood medulloblastoma. Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260 [TBL] [Abstract][Full Text] [Related]
52. Expression of calretinin in odontogenic keratocysts and basal cell carcinomas: A study of sporadic and Gorlin-Goltz syndrome-related cases. Cesinaro AM; Burtini G; Maiorana A; Rossi G; Migaldi M Ann Diagn Pathol; 2020 Apr; 45():151472. PubMed ID: 31982676 [TBL] [Abstract][Full Text] [Related]
58. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Kool M; Jones DT; Jäger N; Northcott PA; Pugh TJ; Hovestadt V; Piro RM; Esparza LA; Markant SL; Remke M; Milde T; Bourdeaut F; Ryzhova M; Sturm D; Pfaff E; Stark S; Hutter S; Seker-Cin H; Johann P; Bender S; Schmidt C; Rausch T; Shih D; Reimand J; Sieber L; Wittmann A; Linke L; Witt H; Weber UD; Zapatka M; König R; Beroukhim R; Bergthold G; van Sluis P; Volckmann R; Koster J; Versteeg R; Schmidt S; Wolf S; Lawerenz C; Bartholomae CC; von Kalle C; Unterberg A; Herold-Mende C; Hofer S; Kulozik AE; von Deimling A; Scheurlen W; Felsberg J; Reifenberger G; Hasselblatt M; Crawford JR; Grant GA; Jabado N; Perry A; Cowdrey C; Croul S; Zadeh G; Korbel JO; Doz F; Delattre O; Bader GD; McCabe MG; Collins VP; Kieran MW; Cho YJ; Pomeroy SL; Witt O; Brors B; Taylor MD; Schüller U; Korshunov A; Eils R; Wechsler-Reya RJ; Lichter P; Pfister SM; Cancer Cell; 2014 Mar; 25(3):393-405. PubMed ID: 24651015 [TBL] [Abstract][Full Text] [Related]
59. [Gorlin-Goltz syndrome: review of the neuroradiological and maxillofacial features illustrated with two clinical cases]. Safronova MM; Arantes M; Lima I; Domingues S; Almeida M; Moniz P Acta Med Port; 2010; 23(6):1119-26. PubMed ID: 21627888 [TBL] [Abstract][Full Text] [Related]
60. Gorlin-Goltz Syndrome: A Case Report and Literature Review with Kim HS; Heo S; Kim KS; Choi J; Yang JY Arch Plast Surg; 2023 Jul; 50(4):384-388. PubMed ID: 37564720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]